[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-344976-105":59,"doc-detail-344976-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","c1orf112-promotes-breast-cancer-growth-by-modulating-the-cell-cycle","C1orf112 promotes breast cancer growth by modulating the cell cycle","","C1orf112 (Chromosome 1 Open Reading Frame 112) is studied for its role in breast cancer progression, with attention to DNA damage repair involvement and abnormal expression across cancers. Expression patterns are analyzed through TCGA and HPA, diagnostic performance is assessed via ROC curves, and prognostic relevance is evaluated using KM plotter and TCGA data. Functional pathway enrichment (GO/KEGG) and experimental validation (qRT-PCR, immunohistochemistry, CCK-8, colony formation, flow cytometry, and in vivo assays) demonstrate that C1orf112 promotes proliferation by modulating cell-cycle regulation and apoptosis-associated mechanisms.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/c1orf112-promotes-breast-cancer-growth-by-modulating-the-cell-cycle/344976/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/c1orf112-promotes-breast-cancer-growth-by-modulating-the-cell-cycle/344976.png","ImageObject",300,407,{"name":92,"@type":93},"Aurora","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-05","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What role does C1orf112 play in breast cancer according to the study?","Question",{"text":112,"@type":113},"C1orf112 is associated with breast cancer progression and promotes tumor growth by influencing cell-cycle regulation.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were expression levels of C1orf112 evaluated?",{"text":117,"@type":113},"Expression was analyzed using TCGA and HPA databases, and experimentally validated in breast cancer cells and tissues using qRT-PCR and immunohistochemistry.",{"name":119,"@type":110,"acceptedAnswer":120},"What functional assays were used to assess C1orf112 effects?",{"text":121,"@type":113},"CCK-8, colony formation, and flow cytometry were used to evaluate effects on proliferation, cell-cycle progression, and apoptosis, with additional in vivo confirmation.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},344976,1790409222,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},4810365810221,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","OPEN ACCESS  \nEDITED BY  \nChen Ling,  \nFudan University, China  \nREVIEWED BY  \nAmit Kumar,  \nUniversity of Maryland, United States Md Sadique Hussain,  \nUttaranchal University, India  \n*CORRESPONDENCE  \nDongyang Liu,  \n [liu67dy87@163.com](liu67dy87@163.com)[ ](liu67dy87@163.com)Fengfeng Cai,  \n [caifengfeng@tongji.edu.cn](caifengfeng@tongji.edu.cn)[ ](caifengfeng@tongji.edu.cn)Shasha Tang,  \n [Tangss0903@tongji.edu.cn](Tangss0903@tongji.edu.cn)  \n†These authors have contributed equally to this work  \nRECEIVED 10 October 2025  \nREVISED 13 February 2026  \nACCEPTED 16 February 2026  \nPUBLISHED 09 March 2026  \nCITATION  \nFang Y, Zheng Y, Jin L, Luis MA, Zhu X, Yong L, Liu D, Cai F and Tang S (2026) C1orf112 promotes breast cancer growth by modulating the cell cycle.  \nFront. Bioeng. Biotechnol. 14:1717768 .  \ndoi: 10.3389/fbioe.2026.1717768  \nCOPYRIGHT  \n© 2026 Fang, Zheng, Jin, Luis, Zhu, Yong, Liu, Cai and Tang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nTYPE Original Research PUBLISHED 09 March 2026  \nDOI 10.3389/fbioe.2026.1717768  \nC1orf112 promotes breast cancer growth by modulating the cell cycle  \nYuan Fang†, Yikai Zheng†, Lingli Jin†, Manuel A. Luis†, Xiaoxuan Zhu, Liyun Yong, Dongyang Liu*, Fengfeng Cai* and Shasha Tang*  \nDepartment of Breast Surgery, Tongji Hospital, School of Medicine, Tongji University, Shanghai, China  \nBackground: C1orf112 (Chromosome 1 Open Reading Frame 112) is involved in DNA damage repair, and its abnormal expression has been implicated in multiple cancers, including breast cancer. This study explores the function of C1orf112 in breast cancer through bioinformatics and experimental validation.  \nMethods: C1orf112 expression in breast cancer was analyzed using TCGA and HPA databases. Diagnostic efficiency was assessed using receiver operating characteristic (ROC) curves, and its prognostic significance was evaluated via KM plotter and TCGA data. GO and KEGG analyses were performed to explore potential mechanisms. Experimental validation included qRT-PCR and immunohistochemistry to confirm expression levels in breast cancer cells and tissues. Function assays, including CCK-8, colony formation and flow cytometry were conducted to assess the impact of C1orf112 on cell proliferation, cycle progression, and apoptosis.  \nResults: C1orf112 was highly expressed in breast cancer, with bioinformatics and immunohistochemical analysis confirming its upregulation in tumor tissues as its potential as a diagnostic marker. Functional enrichment analysis linked C1orf112 overexpression to cell proliferation-related pathways. Immunohistochemistry revealed associations between C1orf112 expression and ER-positive status, HER2 status, and molecular subtypes. Cellular assays demonstrated that C1orf112 promotes breast cancer proliferation by influencing cell cycle regulation, involving key molecules such as CCNB1 (cyclin B1) . In vivo experiments further confirmed these effects.  \nConclusion: C1orf112 contributes to breast cancer progression in association with cell cycle pathways, making it a potential diagnostic and therapeutic target with clinical applications.  \nKEYWORDS  \napoptosis, breast cancer, C1ORF112, prognosis, proliferation  \nIntroduction  \nAccording to 2022 GLOBOCAN data, breast cancer is the second most commonly diagnosed cancer worldwide. In China alone, 357,000 new cases were reported, accounting for 16.6% of the global total (Sung et al., 2021). Breast cancer significantly influences clinical decision-making, particularly in prognosis assessment, treatment selection, and disease monitoring. Research","cbCaicJKU7iRzaRl","https://ap.wps.com/l/cbCaicJKU7iRzaRl","pdf",6039688,17,"English","# Background\n# Methods\n# Results\n# Conclusion\n# Introduction","[{\"question\":\"What role does C1orf112 play in breast cancer according to the study?\",\"answer\":\"C1orf112 is associated with breast cancer progression and promotes tumor growth by influencing cell-cycle regulation.\"},{\"question\":\"How were expression levels of C1orf112 evaluated?\",\"answer\":\"Expression was analyzed using TCGA and HPA databases, and experimentally validated in breast cancer cells and tissues using qRT-PCR and immunohistochemistry.\"},{\"question\":\"What functional assays were used to assess C1orf112 effects?\",\"answer\":\"CCK-8, colony formation, and flow cytometry were used to evaluate effects on proliferation, cell-cycle progression, and apoptosis, with additional in vivo confirmation.\"}]","C1orf112 promotes breast cancer growth by modulating the cell cycle | PDF",1790056072,43,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/487d6e64c09b211277498fc34ce9fe1e.webp",983,1390,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/506c0c155ebcb8da27663a5081aa9560.webp",982,1388,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7df984ac9e29b1dbe74d7d58cf7483c4.webp",981,1387,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c3dc4a21e4d573464ae70858fb8a60e8.webp",980,1385]